Effect of TRPV1 Antagonist SC0030, a Potent Painkiller, on RANKL‐mediated Osteoclast Differentiation Involved in Bone Resorption
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of TRPV1 Antagonist SC0030, a Potent Painkiller, on RANKL‐mediated Osteoclast Differentiation Involved in Bone Resorption
Authors
Keywords
-
Journal
BULLETIN OF THE KOREAN CHEMICAL SOCIETY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-02-21
DOI
10.1002/bkcs.11992
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Osteoporosis treatment: recent developments and ongoing challenges
- (2017) Sundeep Khosla et al. Lancet Diabetes & Endocrinology
- RANK-RANKL signalling in cancer
- (2016) N. Renema et al. BIOSCIENCE REPORTS
- Clinical challenges in the management of osteoporosis
- (2016) Sheryl Vondracek Clinical Interventions in Aging
- Osteoclasts: more than ‘bone eaters’
- (2014) Julia F. Charles et al. TRENDS IN MOLECULAR MEDICINE
- The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Impact of osteoporosis and bone fracture on health-related quality of life in postmenopausal women
- (2013) S. Palacios et al. CLIMACTERIC
- Nitric oxide induces apoptosis associated with TRPV1 channel-mediated Ca2+ entry via S-nitrosylation in osteoblasts
- (2013) Leiting Pan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Heterocycle-linked Phenylbenzyl Amides as Novel TRPV1 Antagonists and Their TRPV1 Binding Modes: Constraint-Induced Enhancement of In Vitro and In Vivo Activities
- (2012) Nam-Jung Kim et al. Chemistry-An Asian Journal
- RANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy Receptor
- (2012) Christopher A. Nelson et al. STRUCTURE
- Osteoporosis: now and the future
- (2011) Tilman D Rachner et al. LANCET
- The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo
- (2010) Aymen I. Idris et al. BONE
- Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis
- (2010) Joel Jules et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Structural and Functional Insights of RANKL-RANK Interaction and Signaling
- (2010) C. Liu et al. JOURNAL OF IMMUNOLOGY
- Synthesis and structural optimization of multiple H-bonding region of diarylalkyl (thio)amides as novel TRPV1 antagonists
- (2009) Fu-Nan Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists
- (2009) Fu-Nan Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- RANKL induces heterogeneous DC-STAMPloand DC-STAMPhiosteoclast precursors of which the DC-STAMPloprecursors are the master fusogens
- (2009) Kofi A. Mensah et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption
- (2008) F. Rossi et al. BONE
- Expression of ion channels of the TRP family in articular chondrocytes from osteoarthritic patients: changes between native and in vitro propagated chondrocytes
- (2008) K. Gavenis et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Cannabinoid receptors and the regulation of bone mass
- (2007) I Bab et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started